PROGNOSTIC VALUE OF HIGH-SENSITIVITY MODIFIED GLASGOW PROGNOSTIC SCORE IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WHO RECEIVED DOCETAXEL

被引:0
作者
Sakamoto, S. [1 ]
Ando, K. [2 ]
Imamura, Y. [1 ]
Kato, M. [3 ]
Komiya, A. [3 ]
Ichikawa, T. [3 ]
机构
[1] Chiba Univ, Grad Sch Med, Chiba, Japan
[2] Chiba Labor Disaster Hosp, Dept Urol, Chiba, Japan
[3] Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
124
引用
收藏
页码:S175 / S175
页数:1
相关论文
共 50 条
[21]   Prognostic value of ECOG performance status and Gleason score in the survival of castration-resistant prostate cancer: a systematic review [J].
Chen, Wen-Jun ;
Kong, Da-Ming ;
Li, Liang .
ASIAN JOURNAL OF ANDROLOGY, 2021, 23 (02) :163-169
[22]   A prognostic score for patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate post chemotherapy [J].
Templeton, Arnoud J. ;
Omlin, Aurelius Gabriel ;
Pezaro, Carmel Jo ;
Kheoh, Thian San ;
Leibowitz-Amit, Raya ;
Vera-Badillo, Francisco Emilio ;
Tannock, Ian ;
Attard, Gerhardt ;
Amir, Eitan ;
De Bono, Johann Sebastian .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
[24]   Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy [J].
Qu, Yuan-Yuan ;
Dai, Bo ;
Kong, Yun-Yi ;
Ye, Ding-Wei ;
Yao, Xu-Dong ;
Zhang, Shi-Lin ;
Zhang, Hai-Liang ;
Ma, Chun-Guang ;
Yang, Wei-Yi .
ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (01) :110-115
[25]   Geriatric Nutritional Risk Index as a Prognostic Marker for Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel [J].
Chang, Li-Wen ;
Hung, Sheng-Chun ;
Li, Jian-Ri ;
Chiu, Kun-Yuan ;
Yang, Cheng-Kuang ;
Chen, Chuan-Shu ;
Lu, Kevin ;
Chen, Cheng-Che ;
Wang, Shu-Chi ;
Lin, Chia-Yen ;
Cheng, Chen-Li ;
Ou, Yen-Chuan ;
Yang, Shun-Fa ;
Hsu, Chiann-Yi ;
Ho, Szu-Hang ;
Wang, Shian-Shiang .
FRONTIERS IN PHARMACOLOGY, 2021, 11
[26]   Prognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapy [J].
Shimpei Yamashita ;
Yasuo Kohjimoto ;
Takashi Iguchi ;
Hiroyuki Koike ;
Hiroki Kusumoto ;
Akinori Iba ;
Kazuro Kikkawa ;
Yoshiki Kodama ;
Nagahide Matsumura ;
Isao Hara .
BMC Urology, 16
[27]   PROGNOSTIC FACTORS FOR OVERALL SURVIVAL IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER TREATED BY INTERMITTENT CHEMOTHERAPY WITH DOCETAXEL AND PREDNISOLONE [J].
Narita, Shintaro ;
Koie, Takuya ;
Yamada, Shigeyuki ;
Orikasa, Kazuhiko ;
Matsuo, Shigeki ;
Aoki, Hiroshi ;
Ishidoya, Shigeto ;
Hoshi, Senji ;
Tsuchiya, Norihiko ;
Ohyama, Chikara ;
Arai, Yoichi ;
Habuchi, Tomonori .
JOURNAL OF UROLOGY, 2015, 193 (04) :E1086-E1087
[28]   Prognostic role of neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with docetaxel. [J].
Pinar, Atike ;
Ozveren, Ahmet ;
Surmeli, Zeki Gokhan ;
Sanli, Ulus Ali ;
Uslu, Ruchan ;
Karaca, Burcak .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[29]   Prognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapy [J].
Yamashita, Shimpei ;
Kohjimoto, Yasuo ;
Iguchi, Takashi ;
Koike, Hiroyuki ;
Kusumoto, Hiroki ;
Iba, Akinori ;
Kikkawa, Kazuro ;
Kodama, Yoshiki ;
Matsumura, Nagahide ;
Hara, Isao .
BMC UROLOGY, 2016, 16
[30]   Geriatric nutritional risk index as a prognostic marker for patients with metastatic castration-resistant prostate cancer receiving docetaxel [J].
Hsieh, H. ;
Hung, S-C. ;
Ou, Y-C. ;
Wang, S-S. ;
Yang, C-K. ;
Chiu, K-Y. .
EUROPEAN UROLOGY, 2021, 79 :S1191-S1192